Evaluation of the HIV-1 drug resistance to elsulfavirine and the effectiveness of it among Russian treatment-naïve patients

Míreanna comhchosúla

• Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
  de réir: A. V. Kravchenko, et al.
  Foilsithe / Cruthaithe: (2018-07-01)
• Assessment of efficiency of treatment of patients with acute HIV infection with use in the scheme of antiretroviral therapy elsulfavirin
  de réir: Ya. S. Ulyanova, et al.
  Foilsithe / Cruthaithe: (2021-07-01)
• Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV
  de réir: Sara Iannuzzi, et al.
  Foilsithe / Cruthaithe: (2021-07-01)
• Transmitted drug resistance to rilpivirine among antiretroviral‐naïve patients living with HIV from northern Poland
  de réir: Miłosz Parczewski, et al.
  Foilsithe / Cruthaithe: (2014-01-01)
• K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine
  de réir: Nikita Reddy, et al.
  Foilsithe / Cruthaithe: (2024-09-01)